Autoantibody profiling of monoamine oxidase A knockout mice, an autism spectrum disorder model.

Guan-Da Syu, F X Reymond Sutandy, Kevin Chen, Yawei Cheng, Chien-Sheng Chen, Jean C Shih

Brain, behavior, and immunity 2023 Jan

filter terms:

Monoamine oxidase A (MAO A) is the critical enzyme to degrade serotonin in the brain and the knockout mouse exhibits hyperserotonemia and abnormalities that are observed in autism spectrum disorder (ASD). Thus, the MAO A knockout mouse is a valuable model for studying neurological and behavioral impairments in ASD. Based on the immune dysfunction hypothesis, dysregulated humoral immunity may cause neurological impairments. To address this hypothesis, we use high-density proteome microarray to profile the serum antibodies in both wild-type and MAO A knockout mice. The distingue autoantibody signatures were observed in the MAO A knockout and wild-type controls and showed 165 up-regulated and 232 down-regulated autoantibodies. The up-regulated autoantibodies were prone to target brain tissues while down-regulated ones were enriched in sex organs. The identified autoantibodies help bridge the gap between ASD mouse models and humoral immunity, not only yielding insights into the pathological mechanisms but also providing potential biomarkers for translational research in ASD. Copyright © 2022 Elsevier Inc. All rights reserved.

Citation

Guan-Da Syu, F X Reymond Sutandy, Kevin Chen, Yawei Cheng, Chien-Sheng Chen, Jean C Shih. Autoantibody profiling of monoamine oxidase A knockout mice, an autism spectrum disorder model. Brain, behavior, and immunity. 2023 Jan;107:193-200